Dr. Chong Kian Tai

Urology (Urinary & Reproductive System)

Credentials	MBBS, MRCS (Edin), MSc (Research)
Background	Dr Chong is a certified Urologist who manages both basic Urology and complex Urologic Oncology issues. He is a specialist surgeon that works with traditional open methods, advanced key-hole laparoscopic and endoscopic techniques, and also the modern Da Vinci robotic surgical operating systems. He is the first Urologist trained in Southeast Asia to complete the full-time Clinical Urologic-Oncology Fellowship at the prestigious Memorial-Sloan Kettering Cancer Center (MSKCC) in New York, USA. His key professional expertise includes the prevention, diagnosis, treatment and management of prostate, kidney, bladder, testicular and penile cancers. As a dynamic healthcare innovator, researcher and educator, Dr Chong started his research training in Urologic-Oncology Research on prostate cancer immunology at Seattle, Washington, which was funded by Southwest Oncology Group (SWOG, USA) and Agency for Science, Technology and Research (A*STAR, Singapore). Dr Chong was a founding member of the Singapore Urological Cancer Consortium and led several research teams in prostate, kidney, bladder and testicular cancer research. These projects included precision medicine, biomolecular, nanoparticle, bioimaging and novel biomedical device studies. Prior to private practice, he was Adjunct Assistant Professor, Co-Director of Urologic Oncology and Director of Research in the Department of Urology at Tan Tock Seng Hospital (TTSH). In advocating holistic care for urological cancer patients in TTSH, he was previously the Chairman for the Urology Cancer Multidisciplinary Tumour Board, Chairman for Urology Cancer Support Programme, Chairman for Advanced Care Planning Team and Chairman for TTSH Prostate Cancer Support Group for patients and their family.

Credentials

MBBS, MRCS (Edin), MSc (Research)

Background

Dr Chong is a certified Urologist who manages both basic Urology and complex Urologic Oncology issues. He is a specialist surgeon that works with traditional open methods, advanced key-hole laparoscopic and endoscopic techniques, and also the modern Da Vinci robotic surgical operating systems.

He is the first Urologist trained in Southeast Asia to complete the full-time Clinical Urologic-Oncology Fellowship at the prestigious Memorial-Sloan Kettering Cancer Center (MSKCC) in New York, USA. His key professional expertise includes the prevention, diagnosis, treatment and management of prostate, kidney, bladder, testicular and penile cancers.

As a dynamic healthcare innovator, researcher and educator, Dr Chong started his research training in Urologic-Oncology Research on prostate cancer immunology at Seattle, Washington, which was funded by Southwest Oncology Group (SWOG, USA) and Agency for Science, Technology and Research (A*STAR, Singapore). Dr Chong was a founding member of the Singapore Urological Cancer Consortium and led several research teams in prostate, kidney, bladder and testicular cancer research. These projects included precision medicine, biomolecular, nanoparticle, bioimaging and novel biomedical device studies.

Prior to private practice, he was Adjunct Assistant Professor, Co-Director of Urologic Oncology and Director of Research in the Department of Urology at Tan Tock Seng Hospital (TTSH). In advocating holistic care for urological cancer patients in TTSH, he was previously the Chairman for the Urology Cancer Multidisciplinary Tumour Board, Chairman for Urology Cancer Support Programme, Chairman for Advanced Care Planning Team and Chairman for TTSH Prostate Cancer Support Group for patients and their family.